awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38751230-0AE84C1F-0C34-473F-833E-AD9447F50A26
Q38751230-0AE84C1F-0C34-473F-833E-AD9447F50A26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38751230-0AE84C1F-0C34-473F-833E-AD9447F50A26
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
P2860
Q38751230-0AE84C1F-0C34-473F-833E-AD9447F50A26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38751230-0AE84C1F-0C34-473F-833E-AD9447F50A26
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21830ca47d9557eab2d4fe1965983fe944f6adda
P2860
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions.